Science
The race to make COVID antibody therapies cheaper and more potent – Nature.com
Injections of antibodies might prevent mild COVID-19 from becoming severe, but the treatments are expensive and difficult to make.
Human antibodies attacking the coronavirus (artist’s impression).Credit: Science Lab/Alamy
When US President Donald Trump was ill with COVID-19, his physicians administered a bevy of medications some proven, others experimental. But there is one that the president has hailed as a cure: a cocktail of coronavirus antibodies produced by Regeneron Pharmaceuticals in Tarrytown, New York.
The ‘curative’ power of this antibody treatment has yet to be proven. Although it has shown promise in small, early…
-
General19 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General17 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News18 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW
-
General20 hours agoSaints move into AFLW top eight after 14-point win over Giants